Courier Health

Courier Health

SaaS platform coordinating patient services

Overview

Courier Health provides a SaaS platform in biopharma that acts as an integrated command center to improve patient services. It coordinates patient touchpoints across marketing, patient services, and field reimbursement for large biopharma, specialty biotech, and rare disease organizations. The platform consolidates data into a single system of record, enabling real-time coordination, automated scheduling, and AI-driven analytics to support personalized patient engagement. Its subscription-based model plus implementation and training services aims to streamline workflows and improve patient outcomes.

About Courier Health

Simplify's Rating
Why Courier Health is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

Biotechnology

Healthcare

Company Size

51-200

Company Stage

Series B

Total Funding

$70.5M

Headquarters

New York City, New York

Founded

2020

Get referred to Courier Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Courier Health says 2025 customers and therapies supported grew over 400%.
  • Series B funding on April 22, 2026 gives runway for AI hiring.
  • Clients report 15%-20% more patient starts and 10%-12% better persistency.

What critics are saying

  • Veeva and Salesforce can bundle CRM, data, and workflow tools inside existing contracts.
  • Biopharma procurement cycles run long; one failed 2026 pilot blocks 2027 expansion.
  • One lost top-pharma account breaks 2027 growth and threatens the business model.

What makes Courier Health unique

  • Courier Health's 2026 platform unifies intake, benefits, prior auth, and adherence workflows end-to-end.
  • Oak HC/FT led its April 22, 2026 Series B, validating category leadership.
  • The 2026 State of Patient-Centricity surveyed 170 professionals across 87 biopharma companies.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$70.5M

Above

Industry Average

Funded Over

3 Rounds

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Above Average

Industry standards

$35M
$45M
Linktree
$50M
Courier Health
$65M
Substack
$100M
ClickUp

Benefits

Health Insurance

Flexible PTO

Paid Parental Leave

Monthly healthy lifestyle stipend

Career coaching opportunities

Stock Options

Equity

Growth & Insights and Company News

Headcount

6 month growth

2%

1 year growth

-2%

2 year growth

2%
PR Newswire
Apr 22nd, 2026
Courier Health Raises $50 Million Series B to Revolutionize the Biopharma Patient Experience

/PRNewswire/ -- Courier Health, the leading technology company for managing patient experiences, today announced it has raised a $50 million Series B funding...

Fierce Healthcare
Apr 22nd, 2026
Oak HC/FT leads Courier Health's $50M series B to scale AI platform for biopharma patient engagement

Courier Health has raised $50 million in Series B funding led by Oak HC/FT, with participation from existing investors Norwest Venture Partners and Work-Bench. The startup, founded in 2022, has developed an AI-powered platform for biopharma companies to manage the patient journey from prescription through therapy adherence. The platform addresses significant industry challenges: more than half of prescriptions for newly launched specialty drugs never reach patients, according to IQVIA data. Courier Health's AI agents automate tasks including intake, benefits checks and prior authorisation whilst integrating fragmented data across providers, payers and pharmacies. In 2025, Courier Health increased its customer base by over 400% and doubled headcount. The company claims clients see a 15% to 20% increase in patient starts and 10% to 12% improvement in six-month persistency.

The Valdosta Daily Times
Apr 22nd, 2026
Courier Health raises $50 million Series B to revolutionize the biopharma patient experience.

Courier Health raises $50 million Series B to revolutionize the biopharma patient experience. PR Newswire Today at 6:18am PDT NEW YORK, April 22, 2026 /PRNewswire/ - Courier Health, the leading technology company for managing patient experiences, today announced it has raised a $50 million Series B funding round led by Oak HC/FT, with participation from existing investors including Norwest and Work-Bench. This latest investment will fuel continued product innovation and solidify Courier Health's position as the leading solution to orchestrate and personalize patient journeys across the life sciences industry. Despite immense clinical innovation across life sciences, efforts to engage and support prescribed patients still fall short due to siloed data, disparate systems, and poor coordination. According to the 2026 State of Patient-Centricity report, nearly 60 percent of biopharma companies consider their data fragmented or inactionable, and less than 10 percent have sufficient data maturity to leverage AI in a meaningful way. Courier Health solves these pain points by connecting data and systems related to the patient experience, applying intelligence to surface insights and proactively identify at-risk patients, and orchestrating seamless experiences across the patient journey. "Our vision is to re-write the patient experience in healthcare, starting with simplifying and coordinating complex patient journeys for those who depend on innovative medicines," said Danny Sigurdson, Founder and CEO of Courier Health. "Our partnership with Oak HC/FT provides the strategic support and capital to accelerate our mission, scale our platform and agentic AI capabilities, and continue investing in our world-class team to ensure our customers are successful. When our customers are successful, patients achieve better health outcomes, and that is our north star." Courier Health's system includes deep data integrations, intelligent workflows driven by context-rich AI, intuitive user interfaces designed specifically for market access and patient services teams, and AI agents that can execute key tasks for reliable automation and scale. Courier Health manages the end-to-end patient journey from education to patient enrollment, benefits and prior authorization, through therapy initiation and adherence. This equips biopharma teams with the visibility, control, and intelligence they need to ensure high-quality interactions with providers, pharmacies, and, most importantly, patients and their families. "Healthcare, especially life sciences, has long lacked a dedicated, purpose-built platform to manage patients," said Billy Deitch, Partner, Oak HC/FT. "True patient-centricity is often promised but rarely delivered, and Courier Health changes that narrative. They provide essential infrastructure and an incredibly thoughtful AI strategy that biopharma is excited to adopt at a rapid pace. Oak is proud to partner with Danny and his team as they redefine the standard for the patient experience." In 2025, Courier Health increased the number of customers and therapies supported on its platform by over 400% and more than doubled its headcount to meet market demand. The funding will accelerate investment in its team and product to bring its innovative technology to more customers. About Courier Health Courier Health is a New York City-based technology company on a mission to improve the patient experience for hundreds of millions of people living with a chronic condition or rare disease. The company develops and delivers the fastest-growing patient experience solution for the life sciences industry. Companies that choose Courier Health are achieving double-digit improvements to patient starts, time-to-start and ongoing adherence to life-altering therapies. As host of the invite-only Patient Innovators Summit and publisher of The State of Patient-Centricity in Biopharma report, Courier Health is backed by leading investors, including Oak HC/FT, Norwest and Work-Bench. Follow Courier Health on LinkedIn and learn more at www.courierhealth.com. About Oak HC/FT Oak HC/FT is a venture and growth equity firm specializing in investments in fintech and healthcare. Using partnership as a foundation, Oak HC/FT guides companies and founders at every stage, from seed to growth, to create businesses that make a measurable and lasting impact. Founded in 2014, Oak HC/FT has invested in 120 portfolio companies and has more than $7 billion in assets under management. Oak HC/FT is headquartered in Stamford, CT, with an office in San Francisco, CA. Follow Oak HC/FT on LinkedIn and X and learn more at www.oakhcft.com. SOURCE Courier Health This is a paid placement. For further inquiries, please contact PR Newswire directly.

Morningstar
Aug 19th, 2025
Courier Health Launches First-Ever Patient Innovators Awards

Courier Health launches first-ever Patient Innovators Awards PR newswire NEW YORK, Aug. 19, 2025.

Courier Health
Jul 11th, 2024
Courier Health Raises $16.5 Million for Industry’s First Patient CRM Solution Designed for Life Sciences

Courier Health announced a $16.5 million Series A led by Norwest Venture Partners with participation from existing investor Work-Bench. The funding will support continued product innovation and hiring. Learn more.

Recently Posted Jobs

Sign up to get curated job recommendations

Courier Health is Hiring for 15 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →